MDXHF
MedX Health Corp·Healthcare
0.04
0.000%(+0.00)
Market OpenLast Updated: — ET
52W L: $0.0052W H: $0.05
MDXHF NEWS
businesswire.com
Mar 16
MedX Announces Application for Extension of Non-Brokered Private Placement
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated February 27, 2026, when it announced the Initial Closing of the Non-brokered Private Placement to accredited investors originally announced in its Press Release dated February 2, 2026, it has made application to the TSX Venture Exchange for an extension of 30 days to April 15, 2026, within which to effect further closings on this Private.
businesswire.com
Feb 27
MedX Announces $2,700,000 Initial Closing of Non-Brokered Private Placement of Series IV Convertible Loan Notes
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated February 2, 2026, it has surpassed the Minimum Subscription and closed on an Initial Closing of $2,700,000 of the non-brokered Private Placement to accredited investors. The Private Placement is for up to $5,000,000 by issuance of up to 100 Convertible Loan Notes, each with a face value of $50,000 (“Series IV Notes”). The Series IV Notes.
businesswire.com
Feb 2
MedX Announces Non-Brokered Private Placement of Series IV Convertible Loan Notes
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that it is proposing a non-brokered Private Placement to accredited investors of up to $5 million by issuance of up to 100 Convertible Loan Notes, each with a face value of $50,000 (“Series IV Notes”). The Series IV Notes will bear interest at 6% per year, payable Quarterly, and will mature on December 31, 2028 (the “Maturity Date”). The Series IV Notes may be converted, at the.
